Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Comorbid substance abuse disorders have emerged as one of the greatest obstacles to the effective treatment of persons with schizophrenia. Estimates of the prevalence of such comorbidity vary, but as many as half of persons with schizophrenia may suffer from a comorbid drug or alcohol disorder. Younger age, male gender, and lower educational attainment are associated with greater risk for addiction. Persons with schizophrenia and comorbid addiction tend to have an earlier onset of schizophrenia than do those without comorbid addiction. Research does not support a link between specific symptoms of schizophrenia and choice of abused drugs. Rather, drug choice is correlated with the pattern of ambient drug use in the community. Comorbid substance disorders are associated with a variety of poorer outcomes, including increased psychotic symptoms, poorer treatment compliance, violence, housing instability and homelessness, medical problems (including human immunodeficiency virus infection), poor money management, and greater use of crisis-oriented services that result in higher costs of care. Considerable progress has been made over the past decade in understanding the need to integrate substance abuse treatment and mental health treatment to provide more effective care for this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of people diagnosed with a severe mental illness, such as schizophrenia or bipolar disorder, will meet criteria for a substance use disorder in their lifetime.”
From Mobile intervention for individuals with psychosis, dual disorders, and their common comorbidities: A literature review (2019) · cites this paper as [7]
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates
Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack, A. S., Kee, K., Morisson, R. L., & Yadalam, K. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.1.31 · Cited by 587
Co-occurring disorders among mentally ill jail detainees: Implications for public policy.
Abram, K. M., & Teplin, L. A. (1991) · American Psychologist · doi:10.1037//0003-066x.46.10.1036 · Cited by 554
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547
Self-citationAlcohol Use and Abuse in Schizophrenia: A Prospective Community Study
DRAKE, R. E., OSHER, F. C., & WALLACH, M. A. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198907000-00004 · Cited by 470
Mortality and medical comorbidity among psychiatric patients: a review
(1996) · Psychiatric Services · doi:10.1176/ps.47.12.1356 · Cited by 393
Medication noncompliance and substance abuse among patients with schizophrenia
(1996) · Psychiatric Services · doi:10.1176/ps.47.8.853 · Cited by 330
Homelessness and dual diagnosis.
Drake, R. E., Osher, F. C., & Wallach, M. A. (1991) · American Psychologist · doi:10.1037//0003-066x.46.11.1149 · Cited by 267
Cited by
A neurobiological basis for substance abuse comorbidity in schizophrenia
Chambers, R. A., Krystal, J. H., & Self, D. W. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01134-9 · Cited by 548
“Moreover, drug or alcohol use greatly increases the likelihood of rehospitalization, length of hospitalization , need for greater neuroleptic dosage, and treatment noncompliance in schizophrenic patients (Dixon 1999; Gerding et al 1999; Seibyl et al 1993).”
BackgroundGoff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
“Poor nutrition, high rates of smoking and substance abuse, and poor access to medical care have also been described in schizophrenia patients (Brown et al., 1999; Dixon, 1999; Druss et al., 2001a,b; Goff et al., 1992; McCreadie, 2003).”
BackgroundRegulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514
“Thus, mania and drug craving, psychosis, disregulated fear and anxiety, and the sadness, anhedonia, and lethargy that characterize depression all could result from improper functioning of the LS, significant considering the high degree of comorbidity of psychiatric conditions typified by these symptoms [16,55,122,139,…”
BackgroundA unified framework for addiction: Vulnerabilities in the decision process
Redish, A. D., Jensen, S., & Johnson, A. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0800472x · Cited by 501
(1976) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1976.tb140860.x · Cited by 393
Metadata
- Authors
- DIXON, L.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- DIXON, L
- ORCID
- DIXON, L
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 35
- Pages
- S93-S100
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2123037757
- Cited by
- 472
- References
- 35
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 16 · 2022: 15 · 2021: 20 · 2020: 11 · 2019: 23 · 2018: 20 · 2017: 12 · 2016: 19 · 2015: 20 · 2014: 19 · 2013: 24 · 2012: 36
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Sociology and Political Science › Homelessness and Social Issues
- Keywords
- schizophrenia, substance use comorbidity
- MeSH terms
- Alcoholism, Marijuana Abuse, Female, Health Status, Humans, Male, Patient Compliance, Schizophrenia, Violence, Prevalence, Health Care Costs, Diagnosis, Dual (Psychiatry), Substance-Related Disorders, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. https://app.cochat.ai/papers/10.1016/s0920-9964(98)00161-3
- The paper
- DIXON, L. (1999). Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophrenia Research. https://doi.org/10.1016/s0920-9964(98)00161-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.